These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19506445)

  • 1. Arterial hypertension greatly contributes to the development and evolution of cardiovascular and renal diseases. Editorial.
    Ruilope LM
    J Hypertens Suppl; 2009 Jun; 27(3):S1. PubMed ID: 19506445
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension and the kidney.
    Wiederkehr M; Toto R; Fenves AZ; Ram CV
    Semin Nephrol; 2005 Jul; 25(4):236-45. PubMed ID: 16202696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension is the greatest threat to global health. Increases the risk of cardiovascular disease, dementia and kidney disease].
    Kahan T; Carlberg B; Nilsson PM
    Lakartidningen; 2013 May 29-Jun 4; 110(22):1088-9. PubMed ID: 23808078
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular events due to hypertension].
    Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():327-32. PubMed ID: 15171393
    [No Abstract]   [Full Text] [Related]  

  • 6. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.
    Rossignol P; Kessler M; Zannad F
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):59-64. PubMed ID: 23165110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?
    Campese VM; Bianchi S; Bigazzi R
    Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):143-7. PubMed ID: 10757219
    [No Abstract]   [Full Text] [Related]  

  • 8. ARBs for cardiovascular and renal protection in high-risk patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
    [No Abstract]   [Full Text] [Related]  

  • 9. The therapeutic prospects of using L-carnitine to manage hypertension-related organ damage.
    Mate A; Miguel-Carrasco JL; Vázquez CM
    Drug Discov Today; 2010 Jun; 15(11-12):484-92. PubMed ID: 20363359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relations between renin activity and vascular complications of arterial hypertension].
    Bonfanti F; Pecci R; Nortilli R; Brugnara C; Corrocher R
    Minerva Cardioangiol; 1982 Mar; 30(3):75-80. PubMed ID: 7045721
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?].
    Schmieder RE
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arterial hypertension and the kidney].
    Niang A
    Dakar Med; 2008; 53(1):1-6. PubMed ID: 19102111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kidney function and cardiovascular disease. Physiopathologic basis of the association].
    Díez J
    Nefrologia; 2004; 24 Suppl(6):21-6, 187-235. PubMed ID: 15696893
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal function and target organ damage in hypertension.
    Ruilope LM; Bakris GL
    Eur Heart J; 2011 Jul; 32(13):1599-604. PubMed ID: 21444366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.
    Flaa A; Aksnes TA; Strand A; Kjeldsen SE
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):451-61. PubMed ID: 17489670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria and hypertension.
    Ritz E; Nowicki M; Fliser D; Hörner D; Klimm HP
    Kidney Int Suppl; 1994 Nov; 47():S76-80. PubMed ID: 7869676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is activated vitamin D supplementation renoprotective?
    Weir MR
    Hypertension; 2008 Aug; 52(2):211-2. PubMed ID: 18606899
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal, cardiovascular and metabolic effects of fetal programming.
    Koleganova N; Benz K; Piecha G; Ritz E; Amann K
    Nephrol Dial Transplant; 2012 Aug; 27(8):3003-7. PubMed ID: 22851622
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertension and future cardiovascular disease in pediatric renal transplant recipients.
    Flynn JT
    Pediatr Transplant; 2006 May; 10(3):276-8. PubMed ID: 16677348
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes and hypertension: a comprehensive report on management and the prevention of cardiovascular and renal complications.
    Handelsman Y
    J Clin Hypertens (Greenwich); 2011 Apr; 13(4):221-3. PubMed ID: 21466616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.